M. Carlock

发表

α2,6-Sialylation is Upregulated in Severe COVID-19 Implicating the Complement Cascade

D. Bar-Sagi, T. Ross, L. Mahal, 2022, medRxiv.

Evaluation of determinants of the serological response to the quadrivalent split‐inactivated influenza vaccine

Hyungwon Choi, C. Vogel, E. Ghedin, 2022, Molecular systems biology.

Predicting seasonal influenza vaccine response using systemic gene expression profiling

C. Forst, D. Gresham, E. Ghedin, 2022, medRxiv.

Emotional Distress, Targeted Rejection, and Antibody Production After Influenza Vaccination in Adolescence

T. Ross, Katherine B. Ehrlich, M. Carlock, 2022, Psychosomatic medicine.

Proteomic Signatures of the Serological Response to Influenza Vaccination in a Large Human Cohort Study

Hyungwon Choi, C. Vogel, S. Pushalkar, 2022, bioRxiv.

Complex changes in serum protein levels upon recovery from SARS-CoV2 infection

Hyungwon Choi, C. Vogel, S. Pushalkar, 2022 .

Prevaccination Glycan Markers of Response to an Influenza Vaccine Implicate the Complement Pathway

C. Vogel, S. Pushalkar, T. Ross, 2022, Journal of proteome research.

Vaccination History, Body Mass Index, Age, and Baseline Gene Expression Predict Influenza Vaccination Outcomes

C. Forst, D. Gresham, E. Ghedin, 2022, Viruses.

α2,6-Sialylation Is Upregulated in Severe COVID-19, Implicating the Complement Cascade

D. Bar-Sagi, T. Ross, L. Mahal, 2022, ACS infectious diseases.

Glycomic Analysis Identifies Pre-Vaccination Markers of Response to Influenza Vaccine, Implicating the Complement Pathway

S. Pushalkar, T. Ross, L. Mahal, 2022, medRxiv.

Vinyl Sulfone-functionalized Acetalated Dextran Microparticles as a Subunit Broadly Acting Influenza Vaccine

K. Ainslie, T. Ross, L. M. Lifshits, 2023, The AAPS Journal.

Development of a broadly active influenza intranasal vaccine adjuvanted with self-assembled particles composed of mastoparan-7 and CpG

K. Ainslie, H. Staats, T. Ross, 2023, Frontiers in Immunology.

Impact of age and pre-existing influenza immune responses in humans receiving split inactivated influenza vaccine on the induction of the breadth of antibodies to influenza A strains

James D. Allen, T. Vogel, S. Delagrave, 2017, PloS one.

Functional antibody-dependent cell mediated cytotoxicity (ADCC) responses to vaccine and circulating influenza strains following vaccination.

D. Steinhauer, T. Ross, He-ying Sun, 2022, Virology.

Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection

N. Petrovsky, T. Ross, S. Turville, 2021, bioRxiv.

Urine Metabolome Dynamics Discriminate Influenza Vaccination Response

T. Ross, Drew R. Jones, Yik Siu, 2023, Viruses.

Structural insights into the broad protection against H1 influenza viruses by a computationally optimized hemagglutinin vaccine

R. DuBois, T. Ross, Julianna Han, 2023, Communications biology.

Elicitation of Protective Antibodies against a Broad Panel of H1N1 Viruses in Ferrets Preimmune to Historical H1N1 Influenza Viruses

James D. Allen, T. Vogel, S. Delagrave, 2017, Journal of Virology.

Impact of age and pre-existing immunity on the induction of human antibody responses against influenza B viruses

T. Ross, H. Kleanthous, M. Ramgopal, 2019, Human vaccines & immunotherapeutics.

Evaluation of determinants of the serological response to the split-inactivated influenza vaccine

C. Vogel, E. Ghedin, S. Wu, 2021, medRxiv.

Zinc Carnosine Metal-Organic Coordination Polymer as a Potent Broadly Active Influenza Vaccine Platform with In Vitro Shelf-Stability.

K. Ainslie, T. Ross, L. M. Lifshits, 2023, Molecular pharmaceutics.

Differential cross-reactivity to the influenza B virus haemagglutinin underpins lineage-specific susceptibility between birth cohorts

I. Barr, A. Wheatley, S. Rockman, 2023, bioRxiv.

A computationally optimized broadly reactive hemagglutinin vaccine elicits neutralizing antibodies against influenza B viruses from both lineages

M. Carlock, Ted M. Ross, 2023, Scientific reports.

Immunogenicity of an adjuvanted broadly active influenza vaccine in immunocompromised and diverse populations

K. Ainslie, E. Bachelder, M. Carlock, 2023, Bioengineering & translational medicine.

Longitudinal assessment of human antibody binding to hemagglutinin elicited by split-inactivated influenza vaccination over six consecutive seasons

M. Carlock, H. Hanley, T. Ross, 2024, PloS one.

Leveraging Pre-Vaccination Antibody Titers across Multiple Influenza H3N2 Variants to Forecast the Post-Vaccination Response

M. Carlock, T. Ross, J. Allen, 2024, medRxiv.

Immune imprinting in early life shapes cross-reactivity to influenza B virus haemagglutinin.

A. Wheatley, M. Koutsakos, J. Juno, 2024, Nature microbiology.